Effect on later sexual function · Postmenopausal women
5 findings from 1 review
no estimate extracted
1 study · 272 participants
Very low
no estimate extracted
6 studies · 608 participants
Moderate
no estimate extracted
1 study · 104 participants
Very low
Show 2 more findings
Estrogen + progestogens · symptomatic or early postmenopausal women1.
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Relief of overall pain ‐ reported as pelvic pain ‐ 3 months · women with endometriosis
GnRHas may leads to higher relief of overall pain ‐ reported as pelvic pain ‐ 3 months compared with placebo (low certainty).
1 finding from 1 review
Relief of painful symptoms ‐ Dysmenorrhoea · women with endometriosis
GnRHas may leads to higher relief of overall pain ‐ reported as dysmenorrhoea ‐ 3 months compared with placebo (low certainty).
1 finding from 1 review
Relief of overall pain ‐ reported as dyspareunia ‐ 3 months · women with endometriosis
GnRHas may leads to higher relief of overall pain ‐ reported as dyspareunia ‐ 3 months compared with placebo (low certainty).
1 finding from 1 review
Relief of overall pain ‐ reported as pelvic tenderness ‐ 6 months · women with endometriosis
GnRHas may leads to higher relief of overall pain ‐ reported as pelvic tenderness scores‐ 3… compared with placebo (low certainty).
1 finding from 1 review
Relief of overall pain ‐ reported as pelvic induration ‐ 6 months · women with endometriosis
GnRHas showed no clear difference in relief of overall pain ‐ reported as pelvic induration scores ‐ 3… compared with placebo (low certainty).
1 finding from 1 review
Live birth rate per couple · assisted reproduction technology cycles
It is very uncertain whether glucocorticoids changes live birth rate per couple compared with no glucocorticoids or placebo (very low certainty).
1 finding from 1 review
Miscarriage · assisted reproduction technology cycles
It is very uncertain whether glucocorticoids changes miscarriage rate per couple compared with no glucocorticoids or placebo (very low certainty).
1 finding from 1 review
Ectopic pregnancy rate per couple · assisted reproduction technology cycles
It is very uncertain whether glucocorticoids changes incidence of ectopic pregnancies per couple compared with no glucocorticoids or placebo (very low certainty).
1 finding from 1 review
Incidence of OHSS per couple (mild‐severe) · assisted reproduction technology cycles
It is very uncertain whether glucocorticoids changes incidence of OHSS per couple (mild–severe) compared with no glucocorticoids or placebo (very low certainty).
1 finding from 1 review
Multiple pregnancy rate · assisted reproduction technology cycles
It is very uncertain whether glucocorticoids changes incidence of multiple pregnancies per couple compared with no glucocorticoids or placebo (very low certainty).
1 finding from 1 review
Ongoing pregnancy rate per couple · assisted reproduction technology cycles
It is very uncertain whether glucocorticoids changes ongoing pregnancy rate per couple compared with no glucocorticoids or placebo (very low certainty).
1 finding from 1 review
Clinical pregnancy rate · assisted reproduction technology cycles
Glucocorticoids showed no clear difference in clinical pregnancy rate per couple –pregnancy rate per couple… compared with no glucocorticoids or placebo (low certainty).
4 findings from 1 review
OR 1.17 [0.95, 1.44]
13 studies · 1967 participants
Low
OR 1.2 [0.87, 1.67]
6 studies · 780 participants
Very low
OR 1.15 [0.87, 1.5]
7 studies · 1187 participants
Very low
Show 1 more finding
Clinical pregnancy rate per couple – subgroup IVF · assisted reproduction technology cycles
It is very uncertain whether glucocorticoids changes clinical pregnancy rate per couple – subgroup IVF compared with no glucocorticoids or placebo (very low certainty).
1 finding from 1 review
Clinical pregnancy rate per couple – subgroup ICSI · assisted reproduction technology cycles
It is very uncertain whether glucocorticoids changes clinical pregnancy rate per couple – subgroup ICSI compared with no glucocorticoids or placebo (very low certainty).
1 finding from 1 review
Live birth rate per couple · patients with male subfertility
It is very uncertain whether antioxidants changes live birth rate per couple randomised compared with placebo or no treatment (very low certainty).
1 finding from 1 review
Clinical pregnancy rate · patients with male subfertility
Antioxidants may leads to higher clinical pregnancy rate per couple randomised compared with placebo or no treatment (low certainty).
1 finding from 1 review
Adverse events ‐ Miscarriage · patients with male subfertility
It is very uncertain whether antioxidants changes adverse events ‐ Miscarriage compared with placebo or no treatment (very low certainty).
1 finding from 1 review
Gastrointestinal adverse events · patients with male subfertility
Antioxidants may leads to higher adverse events ‐ Gastrointestinal compared with placebo or no treatment (low certainty).
1 finding from 1 review